Press Releases

Oct 16, 2025 7:00am EDT

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

Sep 30, 2025 7:00am EDT

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

Sep 15, 2025 7:00am EDT

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

Sep 02, 2025 7:00am EDT

CollPlant to Present at the 2025 International Conference on Biofabrication

Aug 25, 2025 7:00am EDT

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

Aug 20, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 05, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Jul 14, 2025 7:00am EDT

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

Jun 09, 2025 7:00am EDT

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

Jun 04, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS